share_log

SVB Securities Maintains Outperform on AlloVir, Raises Price Target to $19

SVB Securities Maintains Outperform on AlloVir, Raises Price Target to $19

SVB Securities维持AlloVir的跑赢大盘,将目标股价上调至19美元
Benzinga ·  2023/04/26 10:36

SVB Securities analyst Mani Foroohar maintains AlloVir (NASDAQ:ALVR) with a Outperform and raises the price target from $16 to $19.

SVB证券分析师Mani Forohar维持阿洛维尔(纳斯达克:ALVR)的强于大盘,并将目标价从16美元上调至19美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发